LINC01106 and non-small cell lung carcinoma: LINC01106 is upregulated in lung adenocarcinoma, non-small cell lung cancer, and bladder cancer (73–75) and functions as a novel diagnostic and prognostic marker in colorectal and gastric adenocarcinomas (76, 77).